ReShape Lifesciences and OpenLoop Sign Agreement to Provide Nationwide Virtual Health Services for Weight Loss and Wellness Through reshapecare™
26. Mai 2022 08:30 ET
|
ReShape Lifesciences Inc
SAN CLEMENTE, Calif. and DES MOINES, Iowa, May 26, 2022 (GLOBE NEWSWIRE) -- ReShape Lifesciences™ (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company and...
ReShape Lifesciences™ Reports First Quarter 2022 Financial Results and Provides Corporate Update
23. Mai 2022 08:00 ET
|
ReShape Lifesciences Inc
March 2022 Revenues Exceeded January’s and February’s, Combined, Indicating DTC Campaign and Other Visibility Activities are Driving Significant Demand for Lap-Band® Procedures Conference Call to be...
ReShape Lifesciences™ Announces Vernon Vincent to be Recognized as the Distinguished Industry Partner at the ASMBS 2022 LEAD Gala and Awards
19. Mai 2022 08:30 ET
|
ReShape Lifesciences Inc
SAN CLEMENTE, Calif., May 19, 2022 (GLOBE NEWSWIRE) -- ReShape Lifesciences™ (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that Vernon...
ReShape Lifesciences™ to Announce Financial Results for the First Quarter Ended March 31, 2022 and Provide Corporate Update
16. Mai 2022 08:30 ET
|
ReShape Lifesciences Inc
SAN CLEMENTE, Calif., May 16, 2022 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that it...
ReShape Lifesciences to Present at the Q2 Investor Summit
26. April 2022 08:30 ET
|
ReShape Lifesciences Inc
SAN CLEMENTE, Calif., April 26, 2022 (GLOBE NEWSWIRE) -- ReShape Lifesciences™ (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that Bart...
ReShape Lifesciences™ Reports Year Ended 2021 Financial and Operating Results and Provides Corporate Update
28. März 2022 16:05 ET
|
ReShape Lifesciences Inc
SAN CLEMENTE, Calif., March 28, 2022 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today reported...
ReShape Lifesciences™ Experiences Continued Momentum of Direct-to-Consumer Marketing Campaign for the Lap-Band®
24. März 2022 08:30 ET
|
ReShape Lifesciences Inc
New Generation of Patients are Engaged as Evidenced by Surge in Website Traffic and Doctor Referrals Bariatric Surgeons Seeing Increases in Patient Consultations and Procedures Insurance...
ReShape Lifesciences™ to Announce Financial Results for the Year Ended December 31, 2021 and Provide Corporate Update
17. März 2022 09:07 ET
|
ReShape Lifesciences Inc
Full Year Revenue Increased by Approximately 20%, from $11.3 M to $13.6 M $22.8 M in Cash and Cash Equivalents as of December 31, 2021 Company Eliminated All Debt from Balance Sheet Webcast to be...
ReShape Lifesciences to Participate in Investor Conferences in March
09. März 2022 08:30 ET
|
ReShape Lifesciences Inc
SAN CLEMENTE, Calif., March 09, 2022 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced...
ReShape Lifesciences™ to Participate in the American Society for Metabolic and Bariatric Surgery’s (ASMBS) Leadership Academy and re-UNITED Meeting January 19-22, 2022 in Las Vegas
18. Januar 2022 08:30 ET
|
ReShape Lifesciences Inc
Company to Present and Exhibit its Next-Generation Lap-Band® Program Including its Supportive reshapecare™ Virtual Health Coaching Platform Shelly Russell, Vice President Field Operations of ReShape...